Texas Tech Researcher Aims to Delay the Onset of Alzheimer's Disease
Oct 20, 2023
Andrew Shin received a grant to study how the optimal dosage of the BCAA-lowering compound BT2 can effectively treat Alzheimer’s Disease symptoms.
Tags: Feature Stories, College of human sciences, Provost, TTU Features, Vice President for Research, Academics, Stories, Research